BREAKING
Eli Lilly and Company (LLY) to acquire Orna Therapeutics 42 minutes ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 2 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 2 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 3 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 5 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 5 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 6 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 6 hours ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 6 hours ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 3 days ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 42 minutes ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 2 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 2 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 3 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 5 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 5 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 6 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 6 hours ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 6 hours ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 3 days ago
ADVERTISEMENT
Market News

Biocept Inc (BIOC) Q3 2020 Earnings Call

Biocept Inc  (NASDAQ: BIOC) Q3 2020 earnings call dated Nov. 12, 2020 Corporate Participants: Bruce Voss — Investor Relations Michael W. Nall — President and Chief Executive Officer Tim Kennedy — Chief Financial Officer and Senior Vice President of Operations Michael C. Dugan — Senior Vice President, Chief Medical Officer and Medical Director Analysts: Jason McCarthy — Maxim Group — Analyst Sally Yanchus — Brookline Capital Markets […]

$BIOC November 13, 2020 1 min read

Biocept Inc  (NASDAQ: BIOC) Q3 2020 earnings call dated Nov. 12, 2020

Corporate Participants:

Bruce Voss — Investor Relations

Michael W. Nall — President and Chief Executive Officer

Tim Kennedy — Chief Financial Officer and Senior Vice President of Operations

Michael C. Dugan — Senior Vice President, Chief Medical Officer and Medical Director

ADVERTISEMENT

Analysts:

Jason McCarthy — Maxim Group — Analyst

Sally Yanchus — Brookline Capital Markets — Analyst

____

To read the full earnings call transcript, click here.

ADVERTISEMENT